Clinical Trial: A Phase I Study of Intra-Arterial Yttrium-90 Radioembolization for Unresectable Pancreatic Cancer

U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07898683) titled 'A Phase I Study of Intra-Arterial Yttrium-90 Radioembolization for Unresectable Pancreatic Cancer' on Oct. 08.

Brief Summary: This clinical study aims to evaluate the safety and tolerability of intra-arterial Yttrium-90 (90Y) glass microspheres in patients with unresectable pancreatic adenocarcinoma. The study will assess radiation dose distribution, adverse effects, and preliminary efficacy following selective arterial radioembolization.

Study Start Date: Feb. 11, 2025

Study Type: INTERVENTIONAL

Condition: Pancreatic Cancer Non-resectable

Intervention: OTHER: Transarterial Radioembolization

Selective intra-arterial infusion ...